Michael Millward

Professor, MB BS W.Aust., MA Melb., FRACP

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 9406 Citations
  • 41 h-Index
20022024
If you made any changes in Pure these will be visible here soon.

Research Output 2002 2020

Filter
Abstract/Meeting Abstract
2019

A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors

Goh, J., Gao, B., Markman, B., Gan, H., Voskoboynik, M., Wu, Y-L., Guo, J., Zhou, Q., Zhao, J., Chen, C., Qiu, J., Xu, Y., Yang, L. & Millward, M., Jul 2019, In : Cancer Research. 79, 13, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy

Abed, A., Khattak, A., Millward, M., Chopra, A. & Gray, E., Nov 2019, In : Annals of Oncology. 30, Supplement 9, 1 p., LBA14.

Research output: Contribution to journalAbstract/Meeting Abstract

Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study

Lam, W., Nowak, A., Chen, F., Muruganandan, S., Arunachalam, S., Chin, M., Millward, M., Read, C., Murray, K., Creaney, J. & Lee, Y. C. G., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. S342-S342 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Safety and antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors: Ovarian cancer cohort data

Gao, B., Goh, J., Markman, B., Voskoboynik, M., Gan, H. K., Coward, J., Palmieri, D., So, J., Meniawy, T., Chen, C., Xiang, X., Qiu, J., Xu, Y., Yang, L. & Millward, M., Dec 2019, In : Annals of Oncology. 30, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2018

A Phase 1B Study of the Anti-PD-1 Monoclonal Antibody, Tislelizumab, in Combination with the Parp Inhibitor, Pamiparib, in Advanced Solid Tumors

Friedlander, M., Meniawy, T., Markman, B., Mileshkin, L. R., Harnett, P., Millward, M., Lundy, J., Freimund, A. E., Norris, C., Wu, J., Paton, V., Wang, L. & Gao, B., Aug 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, p. 58-59 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.

Friedlander, M., Meniawy, T., Markman, B., Mileshkin, L. R., Harnett, P., Millward, M., Lundy, J., Freimund, A. E., Norris, C., Mu, S., Paton, V., Wang, L. & Gao, B., 10 Feb 2018, In : Journal of Clinical Oncology. 36, 5, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Clinical implementation of personalised medicine for six high priority WA cancers

Humphries, T., Robinson, C., Giardina, T., Nowak, A., Robinson, S., Iacopetta, B., Stewart, C., Meniawy, T., Kumarasinghe, P., Wood, B., Thomas, C., De Boer, B., Leung, Y., Robbins, P., Van Hazel, G., Ferguson, T., Raftopoulos, S., Millward, M. & Amanuel, B., Nov 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, p. 157-158 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Concordance of genomic mutations in tissue vs circulating tumour DNA (ctDNA) in metastatic melanoma

Calapre, L., Giardina, T., Robinson, C., Reid, A., Al-Ogaili, Z., Pereira, M., Mcevoy, A. C., Warburton, L., Khattak, M. A., Meniawy, T., Millward, M., Amanuel, B., Ziman, M. & Gray, E., Mar 2018, In : CLINICAL & EXPERIMENTAL METASTASIS. 35, 3, p. 187-187 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

5 Citations (Scopus)

Outcomes of patients going through trials at a phase 1 clinical trials unit

Ariyapperuma, M., Herbst, Z., Lim, A., Meniawy, T. & Millward, M., Nov 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, p. 74-74 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2017

A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer

Lickliter, J., Gan, H. K., Gao, B., Grimison, P., Zou, J., Kallender, H., Sun, K., Chen, X., Behren, A., Fernandez-Penas, P., Nagrial, A., Voskoboynik, M., Woods, K., Millward, M. & Meniawy, T., Sep 2017, In : Annals of Oncology. 28, 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.

Friedlander, M., Meniawy, T., Markman, B., Mileshkin, L. R., Harnett, P. R., Millward, M., Lundy, J., Freimund, A. E., Norris, C., Mu, S., Wu, J., Paton, V. E., Wang, L. & Gao, B., 20 May 2017, In : Journal of Clinical Oncology. 35, 5 p.

Research output: Contribution to journalAbstract/Meeting Abstract

A Phase II Trial of the Oral FGF Receptor Inhibitor AZD4547 as 2nd or 3rd Line Therapy in Malignant Pleural Mesothelioma - Trial in Progress

Lam, W-S., Lee, Y. C. G., Creaney, J., Muruganandan, S., Millward, M., Read, C. & Nowak, A., Jan 2017, In : Journal of Thoracic Oncology. 12, 1, p. S1087-S1087 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26

Karim, S., Ding, K., Bradbury, P., Ellis, P., Mittman, N., Sun, X. X., Millward, M., Liu, G., Sun, S., Stockler, M. R., Cohen, V., Blais, N., Sangha, R., Boyer, M., Sasidharan, R., Lee, C., Shepherd, F. A., Goss, G., Seymour, L. & Leighl, N. B., Sep 2017, In : Annals of Oncology. 28, 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Dose escalation/expansion study to investigate the safety, pharmacokinetics, food effect, and antitumor activity of BGB-290 in patients with advanced solid tumors

Lickliter, J., Mileshkin, L., Voskoboynik, M., Millward, M., Freimund, A., Meniawy, T., Tang, T., Wei, R., Li, M. & Paton, V., Sep 2017, In : Annals of Oncology. 28, 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Immunotherapy in patients with concurrent solid organ transplant, HIV, and Hepatitis B and C

Rai, R., Ezeoke, O. M., McQuade, J. L., Zimmer, L., Koo, C., Park, J. J., Ardolino, L., Yip, D., Goldinger, S., Cohen, J. V., Millward, M., Atkinson, V., Kane, A. Y., Ascierto, P. A., Garbe, C., Gutzmer, R., Johnson, D. B., Hellman, M. D., Long, G. V. & Menzies, A. M., Sep 2017, In : Annals of Oncology. 28, 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Liquid biopsies for diagnosis and prognosis of melanoma

Ziman, M., Gray, E., Millward, M., Meniawy, T., Khattak, A. & Zaenker, P., May 2017, In : Australasian Journal of Dermatology. 58, p. 26-27 3 p.

Research output: Contribution to journalAbstract/Meeting Abstract

7 Citations (Scopus)

SEROUS RETINAL DETACHMENT DUE TO FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR IN MALIGNANT PLEURAL MESOTHELIOMA

Arunachalam, S., Lam, W-S., Nowak, A., Creaney, J., Millward, M., Muruganandan, S., Read, C., Lee, G. & Chen, F., Oct 2017, In : Clinical & Experimental Ophthalmology. 45, p. 135-135 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2016

A phase I dose-escalation study of BGB-290, a novel PARP1/2 selective inhibitor in patients with advanced solid tumors

Lickliter, J. D., Gan, H. K., Meniawy, T., Yang, J., Wang, L., Luo, L., Lu, N. & Millward, M., 20 May 2016, In : Journal of Clinical Oncology. 34, 15, 3 p.

Research output: Contribution to journalAbstract/Meeting Abstract

A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors

Desai, J., Markman, B., Sandhu, S. K., Gan, H. K., Friedlander, M., Tran, B., Meniawy, T., Boolell, V., Colyer, D., Norris, C., Ameratunga, M., Yang, J., Li, K., Wang, L., Luo, L., Qin, Z. & Millward, M., 20 May 2016, In : Journal of Clinical Oncology. 34, 15, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract